In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

GPT-5.4 Pro cracked a conjecture in number theory that had stumped generations of mathematicians, using a proof strategy that ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in ...

Emmy Noether was a mathematician who discovered perhaps the most profound idea in contemporary physics. Noether’s theorem, which she formulated in 1915, says that symmetries in the universe give rise ...

FISHER 1 in 1930 stated his “fundamental theorem of natural selection” in the form: “The rate of increase in fitness of any organism at any time is equal to its genetic variance in fitness at that ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recent transactionsRecursion Pharmaceuticals insiders reported 5 transactions totaling $366,367.08. Activity included 2 stock sales and 1 tax payment, with the remaining 2 transactions valued at $0.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...